Copyright © Inderes 2011 - present. All rights reserved.

Karolinska Development

0.34 SEK

-1.29 %

Less than 1K followers

KDEV

NASDAQ Stockholm

Investment

Financials

-1.29 %
-60.41 %
-64.13 %
-65.25 %
-63.90 %
-67.18 %
-81.89 %
-82.42 %
-99.03 %

Karolinska Development is an investment company focused on long-term equity investments in biotechnology and pharmaceutical companies. The company's goal is to develop promising medical innovations stemming from academic research at Karolinska Institutet and other universities in the Nordic region. The company's portfolio includes companies in sectors such as biotechnology and medical technology. Karolinska Development was founded in 2003 and is headquartered in Solna, Sweden.

Read more
Market cap
92.91M SEK
Turnover
866.38K SEK
Revenue
1.84M
EBIT %
-497.83 %
P/E
-
Dividend yield-%
-
Revenue and EBIT-%

Revenue M

EBIT-% (adj.)

EPS and dividend

EPS (adj.)

Dividend %

Financial calendar
13/2
2026

Annual report '25

30/4
2026

Interim report Q1'26

12/5
2026

General meeting '26

ShowingAll content types

Join Inderes community

Don't miss out - create an account and get all the possible benefits

Inderes account
Followings and notifications on followed companies
Analyst comments and recommendations
Stock comparison tool & other popular tools
Create account
Inderes’ Disclaimer can be found here. Detailed information about each share actively monitored by Inderes is available on the company-specific pages on Inderes’ website. © Inderes Oyj. All rights reserved.